Challenges of Providing Access to Cutting-Edge Cancer Medicines in the Countries of Eastern Europe

Challenges of Providing Access to Cutting-Edge Cancer Medicines in the Countries of Eastern Europe

Saved in:
Bibliographic Details
Published in:Frontiers in public health Vol. 6; p. 193
Main Authors: Tomić, Zdenko, Tomas, Ana, Benšova, Zuzana, Tomić, Ljiljana, Horvat, Olga, Varga, Ivan, Paut Kusturica, Milica, Sabo, Ana
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 24-07-2018
Subjects:
balkans
HTA
monoclonal antibodies
protein kinase inhibitors
Public Health
targeted therapy
targeted therapy
HTA
balkans
protein kinase inhibitors
monoclonal antibodies
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Health Economics, a section of the journal Frontiers in Public Health
Reviewed by: Georgi Iskrov, Plovdiv Medical University, Bulgaria; Maja Račić, University of East Sarajevo, Bosnia and Herzegovina
Edited by: Nemanja Rancic, Military Medical Academy, Serbia
ISSN:2296-2565
2296-2565
DOI:10.3389/fpubh.2018.00193